Document is current
Any future updates will be listed below
-
Authors
Bodd, Monica H.
Daniels, Nikki C.
Amonoo, Hermioni L.
Tate, Tyler
Herring, Kris W.
LeBlanc, Thomas W.
- License Information
-
More Information
Article History
Received: 4 July 2022
Accepted: 19 December 2022
First Online: 27 December 2022
Declarations
:
: TWL has received honoraria from AbbVie, Agios/Servier, Astellas, BMS/Celgene, BlueNote, Flatiron, Genentech, GSK, and Pfizer; TWL has received speaker fees from AbbVie, Agios/Servier, and BMS/Celgene; TWL has received research funding from American Cancer Society, AstraZeneca, Duke University, Jazz Pharmaceuticals, NIH, and Seattle Genetics. The other authors have no relevant conflicts to disclose.
: This study received approval from the Institutional Review Board at Duke University School of Medicine (IRB Pro00107967).
: Informed consent was obtained from all individual participants included in the study.
: TWL has received honoraria from AbbVie, Agios/Servier, Astellas, BMS/Celgene, BlueNote, Flatiron, Genentech, GSK, and Pfizer; TWL has received speaker fees from AbbVie, Agios/Servier, and BMS/Celgene; TWL has received research funding from American Cancer Society, AstraZeneca, Duke University, Jazz Pharmaceuticals, NIH, and Seattle Genetics. The other authors have no relevant conflicts to disclose.
